Dayvigo 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FBRYL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,486
Award facts
- Contract value 100% obligated
- $1,485.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,485.60 to AmerisourceBergen Drug Corp for Dayvigo 10 mg tablets (30-count package) on September 24, 2025, with an ultimate completion date of September 25, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides global pharmaceutical support for military healthcare systems.
Dayvigo is a prescription sedative-hypnotic medication used to address insomnia, reflecting the broad therapeutic portfolio that AmerisourceBergen supplies through its DLA contract vehicle. The company's federal contracting demonstrates consistent capability in fulfilling pharmaceutical procurement requirements for the Defense Health Agency and other government healthcare systems, with historical delivery orders ranging from nominal amounts to substantial orders exceeding $45,000. This award exemplifies the routine operational execution of the larger pharmaceutical prime vendor contract structure designed to ensure reliable, competitively-priced medication supply chains supporting military personnel and veteran healthcare needs worldwide.
Quick answers
Who was awarded contract SPE2DB25FBRYL?
SPE2DB25FBRYL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FBRYL worth?
The government has obligated $1,486 on SPE2DB25FBRYL.
Is contract SPE2DB25FBRYL an order under another contract?
Yes. SPE2DB25FBRYL is a delivery order under SPE2DB24D2011, an indefinite delivery contract.
Was contract SPE2DB25FBRYL competed?
The extent of competition for SPE2DB25FBRYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award